Antibiotics LL-E19020 Epsilon and LL-E19020 Epsilon.sub.1

Details Antibiotics LL-E19020 Epsilon and LL-E19020 Epsilon.sub.1 Antibiotics LL-E19020 Epsilon and LL-E19020 Epsilon.sub.1

1991-09-09

1994-02-15

Ivy, C. Warren

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

549414, A61K 3135, C07D31500

Patent

active

052867455

ABSTRACT:
The invention provides antibiotics designated LL-E19020 Epsilon and LL-E19020 Epsilon.sub.1 which are derived from the microorganism Streptomyces lydicus ssp. tanzanius NRRL 18036.

REFERENCES:
patent: 4704276 (1987-11-01), Kantor
patent: 4705688 (1987-11-01), Carter et al.
patent: 4968493 (1990-11-01), Carter et al.
Journal of Antibiotics, 41 (10), 1511-1514 Oct. 1988.
Journal of Chromatography, 484, 381-390 (1989).
Journal of Antibiotics, 41(10), 1293-1299 Oct. 1988.
Journal of Antibiotics, 41(10), 1300-1315 Oct. 1988.
Journal of Antibiotics, 39(10), 1361-1367 Oct. 1986.
Journal of Antibiotics, 42(1), 94-101 Jan. 1989.
Antimicrobial Agents and Chemotherapy, 33 (3), 322-325 Mar. 1989.
Program and Abstracts of the 27th Interscience Conference on Antimicrobial Agents and Chemotherapy, No. 995, p. 270, New York, Oct. 4-7 1987.

Affiliated with

Also associated with

Rating

Antibiotics LL-E19020 Epsilon and LL-E19020 Epsilon.sub.1 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antibiotics LL-E19020 Epsilon and LL-E19020 Epsilon.sub.1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibiotics LL-E19020 Epsilon and LL-E19020 Epsilon.sub.1 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1207242